Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 57 | BES2018 | Next issue

Belgian Endocrine Society 2018

BES 2018

Preoperative treatment of benign insulinoma: diazoxide or lanreotide?

ea0057030 | Preoperative treatment of benign insulinoma: diazoxide or lanreotide? | BES2018

Preoperative treatment of benign insulinoma: diazoxide or lanreotide?

Gilliaux Q , Hanon F , Bertrand C , Donckier J

Introduction: Insulinoma is a rare neuroendocrine tumour of the pancreas. Its resection is the only curative treatment. However, medical therapy may be needed to prevent severe preoperative hypoglycaemia, when surgery is contraindicated, delayed or refused and in case of unresectable metastatic disease. To our knowledge, a comparison between these two medications has never been performed.Case report: We describe the case of a 27-year-old patient without ...